Company research
XBiotech Inc.
CIK 1626878Updated Sep 26, 2026
SecurityXBIT · NASDAQ · equity
XBIT price & chart
Loading TradingView…
NASDAQ:XBIT on TradingView ↗Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 150,082,000Source | 199,093,000Source | 226,615,000Source | 246,103,000Source |
| Property, Plant and Equipment, NetUSD | 23,129,000Source | 24,526,000Source | 24,897,000Source | 26,260,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 125,551,000Source | 172,677,000Source | 200,023,000Source | 157,306,000Source |
| Assets, CurrentUSD | 126,953,000Source | 174,567,000Source | 201,718,000Source | 219,843,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,042,000Source | 1,032,000Source | 760,000Source | 601,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 9,732,000Source | 16,825,000Source | 7,769,000Source | 5,701,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 276,727,000Source | 273,105,000Source | 271,152,000Source | 267,325,000Source |
| Retained Earnings (Accumulated Deficit)USD | -136,377,000Source | -90,837,000Source | -52,306,000Source | -27,749,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | — | 0Source | 826,000Source |
| Stockholders' Equity Attributable to ParentUSD | 140,350,000Source | 182,268,000Source | 218,846,000Source | 240,402,000Source |
| Liabilities and EquityUSD | 150,082,000Source | 199,093,000Source | 226,615,000Source | 246,103,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,929,000Source | 15,105,000Source | 6,100,000Source | 4,066,000Source |
| Accounts Payable, CurrentUSD | 1,535,000Source | 2,223,000Source | 2,516,000Source | 2,408,000Source |
| Deferred Income Tax Liabilities, NetUSD | 5,000Source | — | 0Source | 59,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 6,318,000Source | 2,632,000Source | 3,501,000Source | 1,603,000Source |
| Deferred Tax Liabilities, NetUSD | 5,000Source | 0Source | 0Source | 59,000Source |
| Short-term InvestmentsUSD | — | — | 0Source | 60,172,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 3,622,000Source | 1,753,000Source | 3,262,000Source | 5,062,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | 0Source |
| Increase (Decrease) in Accounts PayableUSD | -688,000Source | -364,000Source | 91,000Source | 357,000Source |
| Deferred Income Tax Expense (Benefit)USD | 5,000Source | 0Source | -59,000Source | -816,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -39,920,000Source | -30,963,000Source | -18,725,000Source | -14,824,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -289,000Source | -1,304,000Source | 61,497,000Source | -63,892,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 289,000Source | 1,304,000Source | 362,000Source | 585,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | 0Source | 14,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -10,250,000Source | 10,450,000Source | -9,000Source | 0Source |
| Dividends paid | — | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -47,126,000Source | -27,346,000Source | 42,717,000Source | -79,677,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 486,000Source | 400,000Source | — | — |
| Income Taxes Paid, NetUSD | -81,000Source | 85,000Source | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 3,333,000Source | -5,529,000Source | -46,000Source | -961,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 3,622,000Source | 1,753,000Source | 3,262,000Source | 5,062,000Source |
| Deferred Other Tax Expense (Benefit)USD | — | 0Source | -59,000Source | -11,000Source |
| DepreciationUSD | 1,686,000Source | 1,745,000Source | 1,744,000Source | 2,614,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 3,333,000Source | -5,529,000Source | 1,893,000Source | -2,800,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | 3,333,000Source | -5,529,000Source | 1,893,000Source | -2,800,000Source |
| General and Administrative ExpenseUSD | 8,295,000Source | 4,714,000Source | 4,662,000Source | 6,305,000Source |
| Income Tax Expense (Benefit)USD | 235,000Source | -32,000Source | 244,000Source | -688,000Source |
| Net Income (Loss) Attributable to ParentUSD | -45,540,000Source | -38,531,000Source | -24,557,000Source | -32,900,000Source |
| Nonoperating Income (Expense)USD | 10,380,000Source | 3,908,000Source | 13,197,000Source | 902,000Source |
| Operating ExpensesUSD | — | — | 37,510,000Source | 37,849,000Source |
| Other Nonoperating Income (Expense)USD | 1,456,000Source | 432,000Source | 883,000Source | -121,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | 4,800Source | — |
| Proceeds from Stock Options ExercisedUSD | — | 200,000Source | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 0Source | 4,010,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cost of RevenueUSD | — | — | 0Source | 651,000Source |
| Operating Income (Loss)USD | -55,685,000Source | -42,471,000Source | -37,510,000Source | -34,490,000Source |
| Other Nonoperating Income (Expense)USD | 1,456,000Source | 432,000Source | 883,000Source | -121,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -45,305,000Source | -38,563,000Source | -24,313,000Source | -33,588,000Source |
| Income Tax Expense (Benefit)USD | 235,000Source | -32,000Source | 244,000Source | -688,000Source |
| Net Income (Loss) Attributable to ParentUSD | -45,540,000Source | -38,531,000Source | -24,557,000Source | -32,900,000Source |
| Earnings Per Share, BasicUSD per share | -1.49Source | -1.26Source | -0.81Source | -1.08Source |
| Earnings Per Share, DilutedUSD per share | -1.49Source | -1.26Source | -0.81Source | -1.08Source |
| Total Revenue | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 30,487,731Source | 30,460,980Source | 30,438,459Source | 30,439,275Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 30,487,731Source | 30,460,980Source | 30,438,459Source | 30,439,275Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 230,000Source | -32,000Source | 303,000Source | 128,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 3,333,000Source | -5,529,000Source | 1,893,000Source | -2,800,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | 3,333,000Source | -5,529,000Source | 1,893,000Source | -2,800,000Source |
| General and Administrative ExpenseUSD | 8,295,000Source | 4,714,000Source | 4,662,000Source | 6,305,000Source |
| Gross ProfitUSD | — | — | 0Source | 3,359,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | -88,000Source | -807,000Source | — | — |
| Investment Income, NetUSD | 5,679,000Source | 9,812,000Source | 10,421,000Source | 3,823,000Source |
| Nonoperating Income (Expense)USD | 10,380,000Source | 3,908,000Source | 13,197,000Source | 902,000Source |
| Operating ExpensesUSD | — | — | 37,510,000Source | 37,849,000Source |
| Research and Development ExpenseUSD | 47,390,000Source | 37,757,000Source | 32,848,000Source | 31,544,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 0Source | 4,010,000Source |